Kamau Therapeutics
Last verified 2026-05-23. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $5.0Mattributed |
|---|---|
| Latest round | series-a, $5.0M, 2025-05-01attributed |
| Founded | 2023 |
| Headquarters | San Francisco, US |
| Industry | bio |
| Stage | series-a |
| Website | kamautx.com |
Gene-correction therapeutics targeting sickle cell and genetic diseases
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-05-01 | series-a | $5.0M | khosla |
Detected tech stack
Cloudflare, WordPress 6.9.4, reCAPTCHA, Flywheel 5.1.0, jQuery Migrate 3.4.1, Elementor 4.0.8, parallax.js 1.0, particles.js, Python, PHP, MySQL, jquery 3.7.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $5.0M | attributed | vc-portfolio named as publisher. No document URL on file. |
| Total raised $5.0M | attributed | vc-portfolio named as publisher. No document URL on file. |
| Company existence | self-reported | kamautx.com, read 2026-05-23 |
| Description | self-reported | kamautx.com, read 2026-05-23 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.